ReviewZhong nan da xue xue bao. Yi xue ban = Journal of Central South University. Medical sciences
[Depressive disorders and olfactory dysfunction].
Review in Zhong nan da xue xue bao. Yi xue ban = Journal of Central South University. Medical sciences. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
Depressive disorder is a highly prevalent psychiatric condition that imposes substantial psychological burden on patients and their families, as well as significant economic costs to society. A close relationship exists between depressive disorders and abnormalities in olfactory function, and depressive disorders are frequently accompanied by marked impairments in social functioning. Patients exhibit dysfunction across multiple dimensions of olfactory processing, including olfactory sensitivity, identification, discrimination, and memory, and these abnormalities are influenced by symptom severity and stage of illness. Individuals with depressive disorder show reduced olfactory bulb volume, structural and functional abnormalities in the olfactory cortex, and altered structural and functional connectivity in emotion-related brain regions, such as the amygdala. These neural alterations are associated not only with olfactory dysfunction but also closely with depressive symptoms, providing a neurobiological basis for understanding the emotional and social deficits accompanying depressive disorders. Olfactory dysfunction associated with depressive disorders is characterized by reduced olfactory sensitivity and impaired odor identification, often accompanied by social withdrawal and other forms of diminished social functioning. Reduced olfactory bulb volume, abnormalities in the structure and functional connectivity of emotion-related regions such as the amygdala, along with neuroendocrine dysregulation and heightened inflammatory responses, may together constitute the key mechanisms linking olfactory impairment and depressive symptoms. Interventions targeting the olfactory pathway, such as olfactory training and inhalation-based aromatherapy, have been shown to improve olfactory function and alleviate depressive symptoms to some extent. This mechanistic framework provides important theoretical support and research directions for early identification, diagnosis, and olfactory pathway-targeted intervention strategies for depressive disorders.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.